Overcoming immune evasion with innovative multi-target approaches for glioblastoma

被引：0
|
作者：
Su, Hai [1 ]
Peng, Yin [1 ]
Wu, Yilong [1 ]
Zeng, Xiaoli [2 ,3 ,4 ]
机构：
[1] Chongqing Med Univ, Dept Neurosurg, Yongchuan Hosp, Chongqing, Peoples R China
[2] Gannan Med Univ, Affiliated Hosp 1, Dept Oncol, Ganzhou, Jiangxi, Peoples R China
[3] Gannan Med Univ, Affiliated Hosp 1, Jiangxi Flagship Oncol Dept Synergy Chinese & West, Ganzhou, Jiangxi, Peoples R China
[4] Gannan Med Univ, Affiliated Hosp 1, Jiangxi Clin Med Res Ctr Canc, Dept Oncol, Ganzhou, Jiangxi, Peoples R China
来源：
FRONTIERS IN IMMUNOLOGY | 2025年 / 16卷
关键词：
glioblastoma; immune evasion; immunotherapy; PD-1; immune checkpoint; TUMOR-INFILTRATING LYMPHOCYTES; RANDOMIZED PHASE-III; REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; RECURRENT GLIOBLASTOMA; INHIBITORY MOLECULES; CHECKPOINT BLOCKADE; UP-REGULATION; GLIOMA; EXPRESSION;
D O I：
10.3389/fimmu.2025.1541467
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Glioblastoma (GBM) cells leverage complex endogenous and environmental regulatory mechanisms to drive proliferation, invasion, and metastasis. Tumor immune evasion, facilitated by a multifactorial network, poses a significant challenge to effective therapy, as evidenced by the limited clinical benefits of monotherapies, highlighting the adaptive nature of immune evasion. This review explores glioblastoma's immune evasion mechanisms, the role of ICIs in the tumor microenvironment, and recent clinical advancements, offering theoretical insights and directions for monotherapy and combination therapy in glioblastoma management.
引用
收藏
页数：8
相关论文
共 50 条
  • [31] Multi-target libraries
    Terrett, N
    DRUG DISCOVERY TODAY, 1999, 4 (04) : 187 - 188
  • [32] Data association approaches in bearings-only multi-target tracking
    Xu Benlian
    Wang Zhiquan
    COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION, 2008, 13 (02) : 489 - 499
  • [33] Potential roles for efferocytosis in glioblastoma immune evasion
    Lorimer, Ian A. J.
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [34] A Previously Unidentified Mechanism of Immune Evasion in Glioblastoma
    Zussman, Benjamin M.
    Deibert, Christopher P.
    Engh, Johnathan A.
    NEUROSURGERY, 2015, 76 (02) : N20 - N21
  • [35] Overcoming immune evasion in pancreatic cancer: the combination matters
    Michl, Patrick
    Krug, Sebastian
    GUT, 2018, 67 (06) : 997 - 999
  • [36] Nano-immunotherapy: Overcoming tumour immune evasion
    Guevara, Maria L.
    Persano, Francesca
    Persano, Stefano
    SEMINARS IN CANCER BIOLOGY, 2021, 69 : 238 - 248
  • [37] Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies
    Houweling, Megan
    Giczewska, Anna
    Abdul, Kulsoom
    Nieuwenhuis, Ninke
    Kuecuekosmanoglu, Asli
    Pastuszak, Krzysztof
    Buijsman, Rogier C.
    Wesseling, Pieter
    Wedekind, Laurine
    Noske, David
    Supernat, Anna
    Bailey, David
    Watts, Colin
    Wurdinger, Thomas
    Westerman, Bart A.
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [38] Dynamic Factorization based Multi-target Bayesian Filter for Multi-target Detection and Tracking
    Li, Suqi
    Yi, Wei
    Kong, Lingjiang
    Wang, Bailu
    2014 IEEE RADAR CONFERENCE, 2014, : 1251 - 1256
  • [39] Rational Design of Multi-Target Estrogen Receptors ERα and ERβ by QSAR Approaches
    Zhao, Qi
    Lu, Yuxi
    Zhao, Yan
    Li, Rongchao
    Luan, Feng
    Cordeiro, M. Natalia D. S.
    CURRENT DRUG TARGETS, 2017, 18 (05) : 576 - 591
  • [40] Epigenetic-based therapy: From single- to multi-target approaches
    Benedetti, Rosaria
    Conte, Mariarosaria
    Iside, Concetta
    Altucci, Lucia
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2015, 69 : 121 - 131
12345